Skip Navigation


Nucleic Acids Research Advance Access originally published online on August 3, 2009
Nucleic Acids Research 2009 37(17):5848-5858; doi:10.1093/nar/gkp604
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (3152K) Freely available
Right arrow Screen PDF (654K) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
37/17/5848    most recent
gkp604v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Doria, M.
Right arrow Articles by Michienzi, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doria, M.
Right arrow Articles by Michienzi, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2009, Vol. 37, No. 17 5848-5858
© 2009 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


RNA

Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection

Margherita Doria1,*, Francesca Neri1, Angela Gallo2,*, Maria Giulia Farace3 and Alessandro Michienzi3,*

1Laboratory of Immunoinfectivology, 2RNA editing Laboratory, Children's Hospital Bambino Gesù, 00165 and 3Department of Experimental Medicine and Biochemical Sciences, University of Rome ‘Tor Vergata’, 00133, Rome, Italy

*To whom correspondence should be addressed. Tel: +39 06 72596054; Fax: +39 06 72596053; Email: a_michienzi{at}yahoo.com

Correspondence may also be addressed to Margherita Doria. Tel: +39 06 72596823; Fax: +39 06 72596822; Email: doria{at}uniroma2.it

Correspondence may also be addressed to Angela Gallo. Tel: +39 06 68592658; Fax: +39 06 68592904; Email: gallo{at}opbg.net

Received April 2, 2009. Revised July 1, 2009. Accepted July 2, 2009.

Adenosine deaminases that act on dsRNA (ADARs) are enzymes that target double-stranded regions of RNA converting adenosines into inosines (A-to-I editing) thus contributing to genome complexity and fine regulation of gene expression. It has been described that a member of the ADAR family, ADAR1, can target viruses and affect their replication process. Here we report evidence showing that ADAR1 stimulates human immuno deficiency virus type 1 (HIV-1) replication by using both editing-dependent and editing-independent mechanisms. We show that over-expression of ADAR1 in HIV-1 producer cells increases viral protein accumulation in an editing-independent manner. Moreover, HIV-1 virions generated in the presence of over-expressed ADAR1 but not an editing-inactive ADAR1 mutant are released more efficiently and display enhanced infectivity, as demonstrated by challenge assays performed with T cell lines and primary CD4+ T lymphocytes. Finally, we report that ADAR1 associates with HIV-1 RNAs and edits adenosines in the 5' untranslated region (UTR) and the Rev and Tat coding sequence. Overall these results suggest that HIV-1 has evolved mechanisms to take advantage of specific RNA editing activity of the host cell and disclose a stimulatory function of ADAR1 in the spread of HIV-1.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.